L'Hôpital central de Yaoundé, en abrégé HCY, est un hôpital public à Yaoundé au Cameroun.

During the past decade, Yaounde Central Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yaounde Central Hospital" #1 sponsor was "ANRS, Emerging Infectious Diseases" with 3 trials, followed by "Yaounde Central Hospital" with 3 trials sponsored, "Cardiologie et Développement" with 1 trials sponsored, "French National Agency for Research on AIDS and Viral Hepatitis" with 1 trials sponsored and "KU Leuven" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yaounde Central Hospital" #1 collaborator was "Yaounde Central Hospital" with 3 trials as a collaborator, "Amana Hospital, Dar es Salaam, Tanzania" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Chantal Biya International Reference Centre for Research on Prevention and Management of HIV/AIDS" with 1 trials as a collaborator and "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Yaounde Central Hospital" are "HIV Infections" (2 trials), "AIDS-Related Opportunistic Infections" (1 trials), "Acute Coronary Syndrome" (1 trials), "Bacterial Meningitis" (1 trials) and "Blood Pressure" (1 trials). Many other conditions were trialed in "Yaounde Central Hospital" in a lesser frequency.

Most popular intervention types in "Yaounde Central Hospital" are "Drug" (9 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "ART with 2 NRTIs plus LPV/r (or ATV/r)" (1 trials), "DREAMM" (1 trials), "Darunavir" (1 trials), "Dolutegravir 50 mg" (1 trials) and "Doxycycline Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yaounde Central Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Yaounde Central Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Yaounde Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yaounde Central Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".